ArticleJournal of thoracic disease2025
Development and validation of a nomogram for predicting pulmonary embolism in patients with pulmonary tuberculosis.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The coexistence of pulmonary tuberculosis (PTB) and pulmonary embolism (PE) is an uncommon clinical condition, and its rarity is associated with a high mortality rate, underscoring the critical importance of early diagnosis. The purpose of this study is to develop and validate a nomogram model for predicting risk of PE in patients with PTB. Methods: We included 694 patients with PTB in the development cohort and 236 patients in the validation cohort from another center. A prediction model was established based on independent risk factors. The nomogram's performance was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC), calibration curve analysis, and decision curve analysis (DCA). Results: D-dimer, age, tumor, chest pain, dyspnea, and surgery were independent risk factors for PTB with PE, and a nomogram model was established to predict PTB with PE. The AUC of the development and validation cohort model was 0.903 and 0.821. The calibration curves for both cohorts showed that the probabilities predicted by the model were very close to the actual probabilities. The DCA also demonstrated that the nomogram model showed significant clinical application value. Conclusions: The risk factor-related nomogram model identified in this study has a high predictive accuracy and provides a clinical application for assessing the risk of PE in patients with tuberculosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.